Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma (GILDA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02409472
Recruitment Status : Completed
First Posted : April 6, 2015
Last Update Posted : April 9, 2015
Sponsor:
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research